DarioHealth Corp. Operating Lease, Impairment Loss
DarioHealth Corp. (DRIO) reported Operating Lease, Impairment Loss of $419.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseImpairmentLoss · last filed 2024-11-07
- DarioHealth Corp. operating lease, impairment loss for the quarter ending 2024-06-30 was $419.00K.
| Period end | Operating Lease, Impairment Loss 3 month | Operating Lease, Impairment Loss 3 month as first filed |
|---|---|---|
| 2024-06-30 | $419.00K 10-Q · filed 2024-11-07 | $418.00K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |